Centene Corporation (0HVB.L)
USD 59.81
(-0.08%)
USD 59.81
(-0.08%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.93 Billion USD | -33.09% |
| 2022 | 4.37 Billion USD | 7.38% |
| 2021 | 4.07 Billion USD | -3.23% |
| 2020 | 4.21 Billion USD | 63.33% |
| 2019 | 2.58 Billion USD | 21.01% |
| 2018 | 2.13 Billion USD | 45.53% |
| 2017 | 1.46 Billion USD | -9.06% |
| 2016 | 1.61 Billion USD | 112.25% |
| 2015 | 759 Million USD | 56.17% |
| 2014 | 486 Million USD | 64.75% |
| 2013 | 295 Million USD | 73.53% |
| 2012 | 170 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.61 Billion USD | 490.48% |
| 2024 Q2 | 1.22 Billion USD | -23.76% |
| 2024 Q3 | 665 Million USD | -45.89% |
| 2023 Q3 | 1.42 Billion USD | -7.04% |
| 2023 Q1 | 1.54 Billion USD | 164.32% |
| 2023 FY | 4.78 Billion USD | 9.29% |
| 2023 Q4 | 273 Million USD | -80.87% |
| 2023 Q2 | 1.53 Billion USD | -0.39% |
| 2022 Q2 | 1.39 Billion USD | -1.07% |
| 2022 Q1 | 1.4 Billion USD | 108.92% |
| 2022 Q3 | 999 Million USD | -28.18% |
| 2022 FY | 4.37 Billion USD | 7.38% |
| 2022 Q4 | 583 Million USD | -41.64% |
| 2021 Q3 | 713 Million USD | -26.8% |
| 2021 Q4 | 673 Million USD | -5.61% |
| 2021 FY | 4.07 Billion USD | -3.23% |
| 2021 Q1 | 1.25 Billion USD | 359.49% |
| 2021 Q2 | 974 Million USD | -22.64% |
| 2020 Q2 | 2.2 Billion USD | 256.15% |
| 2020 Q1 | 618 Million USD | 44.73% |
| 2020 Q4 | 274 Million USD | -73.06% |
| 2020 Q3 | 1.01 Billion USD | -53.79% |
| 2020 FY | 4.21 Billion USD | 63.33% |
| 2019 Q2 | 784 Million USD | -2.12% |
| 2019 Q3 | 568 Million USD | -27.55% |
| 2019 FY | 2.58 Billion USD | 21.01% |
| 2019 Q1 | 801 Million USD | 76.04% |
| 2019 Q4 | 427 Million USD | -24.82% |
| 2018 Q2 | 555 Million USD | -7.81% |
| 2018 Q1 | 602 Million USD | 102.69% |
| 2018 Q4 | 455 Million USD | -12.5% |
| 2018 FY | 2.13 Billion USD | 45.53% |
| 2018 Q3 | 520 Million USD | -6.31% |
| 2017 Q4 | 297 Million USD | -25.38% |
| 2017 Q3 | 398 Million USD | -17.77% |
| 2017 Q2 | 484 Million USD | 45.35% |
| 2017 Q1 | 333 Million USD | -48.69% |
| 2017 FY | 1.46 Billion USD | -9.06% |
| 2016 Q4 | 649 Million USD | 68.57% |
| 2016 FY | 1.61 Billion USD | 112.25% |
| 2016 Q3 | 385 Million USD | -11.29% |
| 2016 Q2 | 434 Million USD | 93.75% |
| 2016 Q1 | 224 Million USD | -1.32% |
| 2015 Q2 | 185 Million USD | 34.06% |
| 2015 FY | 759 Million USD | 56.17% |
| 2015 Q1 | 138 Million USD | -29.95% |
| 2015 Q4 | 227 Million USD | 8.61% |
| 2015 Q3 | 209 Million USD | 12.97% |
| 2014 Q2 | 100 Million USD | 33.33% |
| 2014 Q4 | 197 Million USD | 72.81% |
| 2014 Q3 | 114 Million USD | 14.0% |
| 2014 FY | 486 Million USD | 64.75% |
| 2014 Q1 | 75 Million USD | -16.08% |
| 2013 Q1 | 43.86 Million USD | -70.68% |
| 2013 FY | 295 Million USD | 73.53% |
| 2013 Q3 | 88.74 Million USD | 21.88% |
| 2013 Q4 | 89.37 Million USD | 0.7% |
| 2013 Q2 | 72.81 Million USD | 66.01% |
| 2012 FY | 170 Million USD | 0.0% |
| 2012 Q4 | 149.57 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 2323.521% |
| Accuray Incorporated | 504 Thousand USD | -581249.206% |
| Align Technology, Inc. | 643.33 Million USD | -355.437% |
| Elevance Health Inc. | 133.96 Billion USD | 97.813% |
| AxoGen, Inc. | -21.46 Million USD | 13752.036% |
| Boston Scientific Corporation | 2.34 Billion USD | -25.053% |
| CVS Health Corporation | 13.74 Billion USD | 78.68% |
| Cardinal Health, Inc. | 1.24 Billion USD | -135.72% |
| DaVita Inc. | 1.6 Billion USD | -82.807% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 69.565% |
| Hologic, Inc. | 970.2 Million USD | -202.0% |
| Humana Inc. | 4.01 Billion USD | 26.987% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -167.061% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -303.804% |
| Masimo Corporation | 136.5 Million USD | -2046.52% |
| McKesson Corporation | 3.9 Billion USD | 25.045% |
| Patterson Companies, Inc. | 252.92 Million USD | -1058.451% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | -132.171% |
| ResMed Inc. | 1.31 Billion USD | -121.988% |
| Henry Schein, Inc. | 615 Million USD | -376.423% |
| Teladoc Health, Inc. | -248.55 Million USD | 1278.823% |
| Universal Health Services, Inc. | 1.17 Billion USD | -149.281% |
| Veeva Systems Inc. | 429.33 Million USD | -582.452% |
| Baxter International Inc. | 390 Million USD | -651.282% |
| Becton, Dickinson and Company | 2.11 Billion USD | -38.797% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | -65.837% |
| Danaher Corporation | 5.38 Billion USD | 45.549% |
| Stryker Corporation | 3.88 Billion USD | 24.64% |
| Medtronic plc | 5.14 Billion USD | 43.04% |